Aesculap Biologics, LLC is pleased to announce the launch of its redesigned website. The new website has a clean, uncluttered design, improved functionality, and enhanced rich content to provide both healthcare professionals and patients with essential information about the NOVOCART® 3D Phase 3 clinical trial.
Aesculap Biologics, LLC was established in January 2012 as a new company focused on biological approaches to the repair and regeneration of diseased or damaged tissues. Using a combination of cells, growth factors and smart biomaterial devices, Aesculap Biologics products are intended to stimulate and support the synthesis of new tissue and enhance the body's own regenerative power.
The Phase 3 trial Aesculap Biologics is currently conducting is working to bring NOVOCART® 3D to the U.S. from Europe, where it originated and has been implanted in more than 9,000 patients since 2003. NOVOCART 3D is a tissue engineered cell-based product designed to repair articular cartilage defects of the knee. Future Aesculap Biologics products under development will focus on a similar approach to treating back pain, the second most common neurological ailment in the US.
The development of regenerative products, such as NOVOCART 3D, requires a diverse range of expertise. Aesculap Biologics is comprised of a group of professionals with experience in cell and molecular biology, clinical trial management, cell-based product manufacturing, materials management, quality assurance and control, and regulatory affairs. Biologic approaches to tissue repair and regeneration represent the future in healthcare worldwide. Aesculap Biologics' mission ensures that we will be ready for the challenge.
About Aesculap Biologics, LLC
Aesculap Biologics, LLC, was established in January 2012 as a division of Aesculap, Inc. and is focused on biological approaches to the repair and regeneration of diseased or damaged tissues. Using a combination of cells, growth factors and smart biomaterial devices, Aesculap Biologics products can stimulate and support the synthesis of new tissue and enhance the body's own regenerative power to improve the quality of patients' lives.